Genomic analysis of lymphoma

Potential for clinical application

Wing C. Chan, James Olen Armitage

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The application of gene expression profiling to the study of lymphomas will significantly influence the way these tumors are diagnosed and treated. Diffuse large B-cell lymphoma is now known to consist of several different genetic entities with different clinical presentations and therapeutic outcomes. In both follicular and diffuse large B-cell lymphoma, these studies have shown that host-tumor interactions have a major impact on the clinical course. Findings of gene expression profiling in diffuse large B-cell lymphoma has indicated the frequent up-regulation of the nuclear factor-κ and B-cell receptor signaling pathways in the activated B-cell type. Drugs targeting these pathways may be effective in the treatment of these cases and clinical trials have been initiated based on these findings. Gene expression profiling may assist in the selection of treatments based on specific metabolic pathways shown to be active in a particular lymphoma. These techniques offer the promise of truly personalized medicine for patients with lymphoma.

Original languageEnglish (US)
Pages (from-to)353-360
Number of pages8
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume8
Issue number3
DOIs
StatePublished - Jan 1 2010

Fingerprint

Lymphoma, Large B-Cell, Diffuse
Gene Expression Profiling
Lymphoma
B-Lymphocytes
Precision Medicine
Drug Delivery Systems
Metabolic Networks and Pathways
Neoplasms
Up-Regulation
Therapeutics
Clinical Trials

Keywords

  • Gene expression profiling
  • Lymphoma
  • Personalized medicine

ASJC Scopus subject areas

  • Oncology

Cite this

Genomic analysis of lymphoma : Potential for clinical application. / Chan, Wing C.; Armitage, James Olen.

In: JNCCN Journal of the National Comprehensive Cancer Network, Vol. 8, No. 3, 01.01.2010, p. 353-360.

Research output: Contribution to journalArticle

@article{a28fb31fc07d4d1d93beee4ec9667a5f,
title = "Genomic analysis of lymphoma: Potential for clinical application",
abstract = "The application of gene expression profiling to the study of lymphomas will significantly influence the way these tumors are diagnosed and treated. Diffuse large B-cell lymphoma is now known to consist of several different genetic entities with different clinical presentations and therapeutic outcomes. In both follicular and diffuse large B-cell lymphoma, these studies have shown that host-tumor interactions have a major impact on the clinical course. Findings of gene expression profiling in diffuse large B-cell lymphoma has indicated the frequent up-regulation of the nuclear factor-κ and B-cell receptor signaling pathways in the activated B-cell type. Drugs targeting these pathways may be effective in the treatment of these cases and clinical trials have been initiated based on these findings. Gene expression profiling may assist in the selection of treatments based on specific metabolic pathways shown to be active in a particular lymphoma. These techniques offer the promise of truly personalized medicine for patients with lymphoma.",
keywords = "Gene expression profiling, Lymphoma, Personalized medicine",
author = "Chan, {Wing C.} and Armitage, {James Olen}",
year = "2010",
month = "1",
day = "1",
doi = "10.6004/jnccn.2010.0024",
language = "English (US)",
volume = "8",
pages = "353--360",
journal = "JNCCN Journal of the National Comprehensive Cancer Network",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "3",

}

TY - JOUR

T1 - Genomic analysis of lymphoma

T2 - Potential for clinical application

AU - Chan, Wing C.

AU - Armitage, James Olen

PY - 2010/1/1

Y1 - 2010/1/1

N2 - The application of gene expression profiling to the study of lymphomas will significantly influence the way these tumors are diagnosed and treated. Diffuse large B-cell lymphoma is now known to consist of several different genetic entities with different clinical presentations and therapeutic outcomes. In both follicular and diffuse large B-cell lymphoma, these studies have shown that host-tumor interactions have a major impact on the clinical course. Findings of gene expression profiling in diffuse large B-cell lymphoma has indicated the frequent up-regulation of the nuclear factor-κ and B-cell receptor signaling pathways in the activated B-cell type. Drugs targeting these pathways may be effective in the treatment of these cases and clinical trials have been initiated based on these findings. Gene expression profiling may assist in the selection of treatments based on specific metabolic pathways shown to be active in a particular lymphoma. These techniques offer the promise of truly personalized medicine for patients with lymphoma.

AB - The application of gene expression profiling to the study of lymphomas will significantly influence the way these tumors are diagnosed and treated. Diffuse large B-cell lymphoma is now known to consist of several different genetic entities with different clinical presentations and therapeutic outcomes. In both follicular and diffuse large B-cell lymphoma, these studies have shown that host-tumor interactions have a major impact on the clinical course. Findings of gene expression profiling in diffuse large B-cell lymphoma has indicated the frequent up-regulation of the nuclear factor-κ and B-cell receptor signaling pathways in the activated B-cell type. Drugs targeting these pathways may be effective in the treatment of these cases and clinical trials have been initiated based on these findings. Gene expression profiling may assist in the selection of treatments based on specific metabolic pathways shown to be active in a particular lymphoma. These techniques offer the promise of truly personalized medicine for patients with lymphoma.

KW - Gene expression profiling

KW - Lymphoma

KW - Personalized medicine

UR - http://www.scopus.com/inward/record.url?scp=77949848984&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77949848984&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2010.0024

DO - 10.6004/jnccn.2010.0024

M3 - Article

VL - 8

SP - 353

EP - 360

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

SN - 1540-1405

IS - 3

ER -